Takeda in the frame as Genzyme's white knight?
This article was originally published in Scrip
Executive Summary
In a new twist to Genzyme's protracted takeover saga, Japanese pharma company Takeda has emerged as a potential rival to Sanofi Aventis as an acquisitor, according to media reports. Takeda told Scrip that it had absolutely no comment on the matter.